NGNE peer analysis
Neurogene (NGNE) against its competitors: price, today's move, 1-year return and market value side by side.
NGNE and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALEC Alector | $2.46 | 7.64% | 76.15% | $340.93M |
| DSGN Design Therapeutics | $10.81 | 5.88% | 48.62% | $653.81M |
| FDMT 4D Molecular | $12.47 | 1.80% | 12.18% | $676.74M |
| LXEO Lexeo Therapeutics | $3.15 | 8.82% | -65.68% | $237.23M |
| MGTX MeiraGTx | $9.48 | 5.39% | 7.02% | $864.39M |
| PASG Passage Bio | $3.98 | 14.88% | -38.94% | $12.79M |
| TSHA Taysha Gene Therapies | $4.38 | 1.15% | 10.46% | $1.41B |
| VYGR Voyager Therapeutics | $1.99 | 6.70% | -55.81% | $116.06M |
| NGNE Neurogene | $26.04 | 2.88% | -5.06% | $506.49M |
- NGNE's peers: ALEC (Alector), DSGN (Design Therapeutics), FDMT (4D Molecular), LXEO (Lexeo Therapeutics), MGTX (MeiraGTx), PASG (Passage Bio), TSHA (Taysha Gene Therapies), VYGR (Voyager Therapeutics).
Updated 2026-11-10 04:46 UTC